Patents by Inventor Aisling O'Hara

Aisling O'Hara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8227190
    Abstract: The present invention relates to an accurate, sensitive, and efficient sequential or concurrently sequential method for molecular diagnosis of human papillomavirus (HPV)-based disease, where the method improves the accuracy and reliability of diagnostic and prognostic assessments of HPV-based disease. The method of the invention comprises a primary screen of a sample for HPV nucleic acids, followed by a secondary screen for molecular markers, such as proliferation and cell cycle control group protein markers. The sequential or concurrently sequential method significantly reduces the number of false positive results.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: July 24, 2012
    Assignee: Qiagen Gaithersburg, Inc.
    Inventors: Inna R. Williams, Attila T. Lorincz, Aisling O'Hara
  • Patent number: 7361460
    Abstract: The present invention relates to an accurate, sensitive, and efficient sequential or concurrently sequential method for molecular diagnosis of human papillomavirus (HPV)-based disease, where the method improves the accuracy and reliability of diagnostic and prognostic assessments of HPV-based disease. The method of the invention comprises a primary screen of a sample for HPV nucleic acids, followed by a secondary screen for molecular markers, such as proliferation and cell cycle control group protein markers. The sequential or concurrently sequential method significantly reduces the number of false positive results.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: April 22, 2008
    Assignee: Digene Corporation
    Inventors: Inna R. Williams, Attila T. Lorincz, Aisling O'Hara
  • Publication number: 20070243552
    Abstract: The present invention relates to an accurate, sensitive, and efficient sequential or concurrently sequential method for molecular diagnosis of human papillomavirus (HPV)-based disease, where the method improves the accuracy and reliability of diagnostic and prognostic assessments of HPV-based disease. The method of the invention comprises a primary screen of a sample for HPV nucleic acids, followed by a secondary screen for molecular markers, such as proliferation and cell cycle control group protein markers. The sequential or concurrently sequential method significantly reduces the number of false positive results.
    Type: Application
    Filed: May 24, 2007
    Publication date: October 18, 2007
    Inventors: Inna Williams, Attila Lorincz, Aisling O'Hara
  • Publication number: 20040202996
    Abstract: The present invention relates to an accurate, sensitive, and efficient sequential or concurrently sequential method for molecular diagnosis of human papillomavirus (HPV)-based disease, where the method improves the accuracy and reliability of diagnostic and prognostic assessments of HPV-based disease. The method of the invention comprises a primary screen of a sample for HPV nucleic acids, followed by a secondary screen for molecular markers, such as proliferation and cell cycle control group protein markers. The sequential or concurrently sequential method significantly reduces the number of false positive results.
    Type: Application
    Filed: April 11, 2003
    Publication date: October 14, 2004
    Inventors: Inna R. Williams, Attila T. Lorincz, Aisling O'Hara